Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing the Start Printed Page 15264renewal of certain FDA advisory committees by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the charters of the committees listed below for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed below. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Public Law 92-463 (5 U.S.C. app. 2)).
Authority for these committees will expire on the date indicated below unless the Commissioner formally determines that renewal is in the public interest.
|Name of committee||Date of expiration|
|Anti-Infective Drugs Advisory Committee||October 7, 2002|
|Dermatologic and Ophthalmic Drugs Advisory Committee||October 7, 2002|
|Biological Response Modifiers Advisory Committee||October 28, 2002|
|Technical Electronic Product Radiation Safety Standards Committee||December 24, 2002|
FOR FURTHER INFORMATION CONTACT:
Donna M. Combs, Committee Management Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-5496.Start Signature
Dated: March 1, 2001.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 01-6509 Filed 3-15-01; 8:45 am]
BILLING CODE 4160-01-F